I

Instil Bio Inc
NASDAQ:TIL

Watchlist Manager
Instil Bio Inc
NASDAQ:TIL
Watchlist
Price: 27.62 USD 5.82%
Market Cap: 181.2m USD

EV/EBITDA
Enterprise Value to EBITDA

-3.4
Current
-6.8
Median
5.1
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-3.4
=
Enterprise Value
161.7m USD
/
EBITDA
-47.7m USD
EBITDA Growth EV/EBITDA to Growth
US
I
Instil Bio Inc
NASDAQ:TIL
Average EV/EBITDA: 16.1
Negative Multiple: -3.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 934.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.1
13%
1.2
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
Negative Multiple: -13 213.5 N/A N/A
US
Amgen Inc
NASDAQ:AMGN
14.7
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.9
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -576.6 N/A N/A
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.1 N/A N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-2.5
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A